Patents by Inventor Raylene Alison Reimer

Raylene Alison Reimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of diabetes with milk protein hydrolysate
    Patent number: 8710003
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: April 29, 2014
    Assignee: Nestec S.A.
    Inventors: Raylene Alison Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
  • TREATMENT OF DIABETES WITH MILK PROTEIN HYDROLYSATE
    Publication number: 20100297253
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Application
    Filed: May 18, 2010
    Publication date: November 25, 2010
    Inventors: Raylene Alison REIMER, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
  • Treatment of diabetes with milk protein hydrolysate
    Publication number: 20030004095
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Application
    Filed: May 21, 2002
    Publication date: January 2, 2003
    Inventors: Raylene Alison Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser